Top Analyst Upgrades and Downgrades: AMD, CVS Health, Disney, Fiat Chrysler, Kinross Gold, Kohl's, NVIDIA and More

Investing

Published: November 10, 2017 9:00 am

Last Updated: March 20, 2020 11:25 am

Stocks managed to get that elusive sell-off on Thursday over some disappointment on the timing of tax reform, and the markets looked to open marginally lower on Friday as well. Investors need to understand that stocks have been bumping up against all-time highs. Also note that this bull market is nearing nine years old now, and the trend that has dominated for more than half of that time is that investors keep managing to find new reasons to buy stocks after every sell-off. Investors are also looking for new investing and trading ideas to generate gains and income ahead.

24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new investing ideas and trading for our readers. Some of these analyst reports and research notes cover stocks to buy. Others cover stocks to sell or to avoid.

Additional color and commentary has been added on most of these daily analyst calls. Consensus analyst price target data and valuation metrics are from the Thomson Reuters sell-side research service.

These were the top analyst upgrades, downgrades and other research calls from Friday, November 10, 2017.

Advanced Micro Devices Inc. (NASDAQ: AMD) was reiterated as Buy with a $19 price target (versus an $11.12 prior close) at Jefferies. The firm noted that AMD is undervalued with a big discount to peers in a chip-intensive M&A climate, and that it has been growing revenues rapidly over the past two years. The stock has a 52-week trading range of $6.47 to $15.65 and a consensus analyst price target of $14.23.

CVS Health Corp. (NYSE: CVS) was raised to Buy from Hold with a $79 price target (versus a $69.02 close) at Needham. It has a 52-week range of $66.45 to $84.72 and a consensus price target of $86.75. The shares were indicated up 0.7% at $69.50 on Friday.

Fiat Chrysler Automobiles N.V. (NYSE: FCAU) was raised to Neutral from Sell at Citigroup. It has a 52-week range of $6.87 to $18.33 and a consensus price target of $19.84.

Kinross Gold Corp. (NYSE: KGC) was raised to Outperform from Neutral at Macquarie. Kinross closed up 4.5% at $4.37 on Thursday and was indicated up 1% higher at $4.40 on Friday. It has a 52-week range of $2.88 to $4.91 and has a consensus target price of $5.24.

Kohl’s Corp. (NYSE: KSS) was raised to Outperform from Neutral with a $47 price target (versus a $41.17 close) at Robert W. Baird. The 52-week range is $35.16 to $59.67. The consensus price target is $42.83.

NVIDIA Corp. (NASDAQ: NVDA) was down almost 2% at $205.32 ahead of earnings and was last indicated up 4.5% at $214.67 (above its all-time high of $212.90) after earnings and guidance. Instinet raised it to Neutral from Reduce with a $190 price target. Jefferies reiterated the stock as Buy and raised its target price to $240 from $230. NVIDIA had a 52-week range of $78.50 to $212.90, and its consensus price target is $169.55.

Walt Disney Co. (NYSE: DIS) was up 1.5% at $102.68 ahead of earnings and up 1% at $103.77 afterward despite some weak metrics inside the earnings report. Jefferies maintained its Hold rating and $103 target price on Disney. The 52-week range is $95.78 to $116.10, and the consensus price target is $110.32.

ALSO READ: War Potential Makes Gold a Must-Own Asset: 4 Stocks to Buy Now

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.

Other key analyst calls have been featured below.

Canadian Solar Inc. (NASDAQ: CSIQ) was raised to Buy from Neutral with a $24 price target (versus a $16.84 close) at Roth Capital. Shares were down 10.7% at $16.84 on Thursday and indicated to open 3.5% higher at $17.43 on Friday.

Finish Line Inc. (NASDAQ: FINL) was downgraded to Underperform from Neutral with a $7 price target (versus a $10.00 close) at Cowen. The 52-week range is $6.90 to $24.50.

Globus Medical Inc. (NYSE: GMED) was raised to Neutral from Underperform at Merrill Lynch.

Hyatt Hotels Corp. (NYSE: H) was raised to Buy from Hold with a $78 price target (versus a $69.20 close) at Berenberg.

Perrigo Co. (NASDAQ: PRGO) was raised to Sector Perform from Underperform with an $86 price target (versus an $87.99 close) at RBC Capital Markets.

Sequential Brands Group Inc. (NASDAQ: SQBG) was down 42% at $1.45 on Thursday after earnings and revenues missed expectations. It was downgraded to Hold from Buy with a $1.50 price target (versus a $1.45 close) at Canaccord Genuity.

ALSO READ: 10 Serious Risks and Opportunities for Investors Under Tax Reform and Tax Cuts

Teleflex Inc. (NYSE: TFX) was started as Overweight with a $295 price target (versus a $257.14 close) at Piper Jaffray.

TE Connectivity Ltd. (NYSE: TEL) was started with an Outperform rating and assigned a $105 price target (versus a $92.92 close) at Wells Fargo.

Viking Therapeutics Inc. (NASDAQ: VKTX) was started with a Buy rating and assigned a $7 price target (versus a $2.19 close) at H.C. Wainwright. The 52-week range is $0.88 to $3.24, and the company had just a $62 million market cap, but the stock was indicated down 6% at $2.24.

Zoe’s Kitchen Inc. (NYSE: ZOES) was raised to Buy from Hold with a $16 price target (versus an $11.01 close) at Jefferies.

Thursday’s top analyst upgrades and downgrades included Biogen, Cabot Oil & Gas, CenturyLink, NetApp, Square, T-Mobile, Wix and many more.

Cash Back Credit Cards Have Never Been This Good

Credit card companies are at war, handing out free rewards and benefits to win the best customers. A good cash back card can be worth thousands of dollars a year in free money, not to mention other perks like travel, insurance, and access to fancy lounges. See our top picks for the best credit cards today. You won’t want to miss some of these offers.

Flywheel Publishing has partnered with CardRatings for our coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.